Corient Private Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$169M Sell
466,785
-84,082
-15% -$28.8M 0.23% 82
2026
Q1
$190M Buy
550,867
+13,237
+2% +$4.72M 0.27% 70
2025
Q4
$176M Buy
537,630
+188,531
+54% +$59.8M 0.24% 89
2025
Q3
$97.1M Sell
349,099
-170,285
-33% -$49.4M 0.15% 143
2025
Q2
$145M Sell
519,384
-11,477
-2% -$3.25M 0.19% 111
2025
Q1
$165M Sell
530,861
-33,239
-6% -$9.82M 0.27% 77
2024
Q4
$146M Sell
564,100
-2,087
-0.4% -$619K 0.24% 96
2024
Q3
$182M Sell
566,187
-10,419
-2% -$3.41M 0.28% 77
2024
Q2
$180M Sell
576,606
-299
-0.1% -$87.8K 0.31% 65
2024
Q1
$164M Sell
576,905
-31,495
-5% -$9.22M 0.29% 78
2023
Q4
$175M Buy
608,400
+35,217
+6% +$9.6M 0.32% 66
2023
Q3
$154M Buy
573,183
+7,655
+1% +$1.91M 0.35% 64
2023
Q2
$126M Buy
565,528
+154,879
+38% +$35.9M 0.29% 81
2023
Q1
$99.3M Buy
410,649
+214,168
+109% +$52.6M 0.27% 98
2022
Q4
$51.6M Buy
+196,481
New +$52.7M 0.19% 129

Other funds holding AMGN

Corient Private Wealth's AMGN Position: Q2 2026 in Review

Corient Private Wealth reduced its Amgen (AMGN) stake by 15% in Q2 2026, selling an estimated $28.8M and leaving 466,785 shares worth $169M. The position accounts for 0.23% of the portfolio, ranked #82.

Corient Private Wealth first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $190M in Q1 2026. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Corient Private Wealth held 466,785 shares of Amgen worth $169M as of Q2 2026.
  • Corient Private Wealth sold 84,082 Amgen shares in Q2 2026, an estimated $28.8M.
  • Amgen made up 0.23% of Corient Private Wealth's portfolio in Q2 2026, its #82 holding.
  • Corient Private Wealth first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Amgen position peaked at $190M in Q1 2026.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.